Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome)
- PMID: 10751092
- DOI: 10.1002/(sici)1096-8628(20000306)91:1<66::aid-ajmg12>3.0.co;2-p
Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome)
Abstract
Hereditary Hemorrhagic Telangiectasia (HHT) is easily recognized in individuals displaying the classical triad of epistaxis, telangiectasia, and a suitable family history, but the disease is more difficult to diagnosis in many patients. Serious consequences may result if visceral arteriovenous malformations, particularly in the pulmonary circulation, are unrecognized and left untreated. In spite of the identification of two of the disease-causing genes (endoglin and ALK-1), only a clinical diagnosis of HHT can be provided for the majority of individuals. On behalf of the Scientific Advisory Board of the HHT Foundation International, Inc., we present consensus clinical diagnostic criteria. The four criteria (epistaxes, telangiectasia, visceral lesions and an appropriate family history) are carefully delineated. The HHT diagnosis is definite if three criteria are present. A diagnosis of HHT cannot be established in patients with only two criteria, but should be recorded as possible or suspected to maintain a high index of clinical suspicion. If fewer than two criteria are present, HHT is unlikely, although children of affected individuals should be considered at risk in view of age-related penetration in this disorder. These criteria may be refined as molecular diagnostic tests become available in the next few years.
Similar articles
-
Hereditary hemorrhagic teleangiectasia (Rendu-Osler-Weber disease).Minerva Cardioangiol. 2002 Jun;50(3):221-38. Minerva Cardioangiol. 2002. PMID: 12107402 Review. English, Italian.
-
Multidisciplinary coordinated care of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease).Vasc Med. 2023 Apr;28(2):153-165. doi: 10.1177/1358863X231151731. Epub 2023 Mar 8. Vasc Med. 2023. PMID: 36890671
-
[Genetic diagnostics of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease)].Orv Hetil. 2019 May;160(18):710-719. doi: 10.1556/650.2019.31380. Orv Hetil. 2019. PMID: 31030535 Hungarian.
-
[Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): clinical manifestations and multidisciplinary management].Rev Med Suisse. 2016 May 4;12(517):896-901. Rev Med Suisse. 2016. PMID: 27323484 French.
-
Hereditary hemorrhagic telangiectasia: an update on clinical manifestations and diagnostic measures.Wien Klin Wochenschr. 2006 Mar;118(3-4):72-80. doi: 10.1007/s00508-006-0561-x. Wien Klin Wochenschr. 2006. PMID: 16703249 Review.
Cited by
-
Tamoxifen Therapy for Recurrent Mucosal Bleeding in Hereditary Hemorrhagic Telangiectasia.J Hematol. 2021 Feb;10(1):22-24. doi: 10.14740/jh794. Epub 2021 Feb 6. J Hematol. 2021. PMID: 33643506 Free PMC article.
-
Hereditary hemorrhagic telangiectasia.N Am J Med Sci. 2015 Mar;7(3):125-8. doi: 10.4103/1947-2714.153928. N Am J Med Sci. 2015. PMID: 25839006 Free PMC article.
-
Inverted papillomas and benign nonneoplastic lesions of the nasal cavity.Am J Rhinol Allergy. 2012 Mar-Apr;26(2):157-63. doi: 10.2500/ajra.2012.26.3732. Am J Rhinol Allergy. 2012. PMID: 22487294 Free PMC article. Review.
-
Life-Threatening Intraventricular Rupture of Brain Abscess in a Patient With Undiagnosed Hereditary Hemorrhagic Telangiectasia.Cureus. 2020 Jun 21;12(6):e8732. doi: 10.7759/cureus.8732. Cureus. 2020. PMID: 32714672 Free PMC article.
-
Management of patients with hereditary hemorrhagic telangiectasia undergoing general anesthesia: a cohort from a single academic center's experience.J Anesth. 2013 Oct;27(5):705-11. doi: 10.1007/s00540-013-1601-0. Epub 2013 Apr 5. J Anesth. 2013. PMID: 23558470 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources